EKSO
NASDAQ
US
Ekso Bionics Holdings, Inc. - Common Stock
$9.40
▼ $-1.25
(-11.74%)
Vol 217K
6
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$29.3M
ROE
-90.7%
Margin
-70.7%
D/E
43.98
Beta
0.88
52W
$3–$15
Wall Street Consensus
8 analysts · Apr 20262
Strong Buy
4
Buy
2
Hold
0
Sell
0
Strong Sell
75.0%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 50.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.29 | $-1.33 | $-1.04 |
| Sep 2025 | $-1.17 | $-0.54 | +$0.63 |
| Jun 2025 | $-1.38 | $-1.24 | +$0.14 |
| Mar 2025 | $-1.68 | $-1.80 | $-0.12 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $5.1M | $3.4M | $2.1M | $4.2M | $3.1M |
| Net Income | — | -$3.4M | -$2.9M | -$2.7M | -$1.4M | -$4.7M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -86.6% | -86.6% | -86.6% | -86.6% | -90.7% | -90.7% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -131.7% | -75.7% | -75.7% | -75.7% | -70.7% | -70.7% |
| Gross Margin | 39.8% | 51.5% | 51.5% | 51.5% | 53.5% | 53.5% |
| D/E Ratio | 41.95 | 41.95 | 41.95 | 41.95 | 43.98 | 43.98 |
| Current Ratio | 2.38 | 2.38 | 2.38 | 2.38 | 1.66 | 1.66 |
Key Ratios
ROA (TTM)
-42.3%
P/S (TTM)
1.99
P/B
1.1
EPS (TTM)
$-5.57
CF/Share
$-1.03
Rev Growth 3Y
+16.8%
52W High
$14.97
52W Low
$2.73
$2.73
52-Week Range
$14.97
Financial Health
Free Cash Flow
-$4.5M
Net Debt
$3.5M
Cash
$1.2M
Total Debt
$4.6M
As of Dec 31, 2025
How does EKSO compare to Health Care peers?
Peer group: Micro-cap Health Care (All) · 241 companies
EKSO valuation vs Health Care peers
P/E ratio
—
▼
0%
below
peers
(30.7)
vs Peers
vs Industry
Undervalued
P/S ratio
2.0
▼
23%
below
peers
(2.6)
vs Peers
vs Industry
Pricier
P/B ratio
1.1
▼
62%
below
peers
(2.8)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.7%)
vs Peers
vs Industry
Low yield
EKSO profitability vs Health Care peers
ROE
-90.7%
▼
136%
below
peers
(-38.5%)
vs Peers
vs Industry
Weak
Net margin
-70.7%
▼
187%
below
peers
(-24.7%)
vs Peers
vs Industry
Weak
Gross margin
53.5%
▲
1%
above
peers
(52.9%)
vs Peers
vs Industry
In line
ROA
-42.3%
▼
99%
below
peers
(-21.2%)
vs Peers
vs Industry
Weak
EKSO financial health vs Health Care peers
D/E ratio
44.0
▲
128%
above
peers
(19.3)
vs Peers
vs Industry
High debt
Current ratio
1.7
▼
23%
below
peers
(2.2)
vs Peers
vs Industry
Low liquidity
Beta
0.9
▼
16%
below
peers
(1.1)
vs Peers
vs Industry
More volatile
EKSO fundamentals radar
EKSO
Peer median
Industry
EKSO profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
EKSO vs peers: key metrics
Latest News
No related news yet